Literature DB >> 6236672

Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP.

L Bergqvist, J Brismar, E Cederquist, L Darte, Y Naversten, J Palmer.   

Abstract

The bone-imaging agents MDP, DPD and HDP were compared radiochemically (only minor differences were found) in 12 patients with prostatic and 12 patients with breast carcinoma. Each patient received both MDP and either DPD or HDP. The scintigraphic examinations were compared visually and quantitatively. The uptake ratio normal bone/soft tissue was higher for DPD and HDP than for MDP. The ratio pathologic bone/normal bone was highest for MDP, particularly for prostatic carcinoma. The differences in this ratio for breast carcinoma were in general non-significant. The observed differences were minor and of little practical importance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236672     DOI: 10.1177/028418518402500310

Source DB:  PubMed          Journal:  Acta Radiol Diagn (Stockh)        ISSN: 0567-8056


  4 in total

1.  Chronic medial knee pain without history of prior trauma: correlation of pain at rest and during exercise using bone scintigraphy and MR imaging.

Authors:  Florian M Buck; Alexander Hoffmann; Bernhard Hofer; Christian W A Pfirrmann; Bernhard Allgayer
Journal:  Skeletal Radiol       Date:  2008-12-03       Impact factor: 2.199

2.  Clinical comparison of 99mTc-HMDP and 99mTc-MDP. A multicenter study.

Authors:  B Delaloye; A Delaloye-Bischof; R Dudczak; K Koppenhagen; F Mata; A Penafiel; F D Maul; J Pasquier
Journal:  Eur J Nucl Med       Date:  1985

3.  Altered Biodistribution of 99mTc-DPD on Bone Scan After Intravenous Iron Supplement.

Authors:  Eonwoo Shin; Minyoung Oh; Changhwan Sung; Ki-Hun Kim; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2017-07-25

Review 4.  The development of musculoskeletal radiology for 100 years as presented in the pages of Acta Radiologica.

Authors:  Mats Geijer; Fatih Inci; Nektarios Solidakis; Pawel Szaro; Bariq Al-Amiry
Journal:  Acta Radiol       Date:  2021-10-19       Impact factor: 1.990

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.